Novartis Must Close Plant as FDA Reviews Possible Opioid, OTC Mix-Up
Novartis had to temporarily shutter its Lincoln, Neb., OTC drug plant after being hit with a 13-page Form 483 noting “a pattern of problems” with investigations into foreign tablets that appeared in product batches.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.